Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-Year follow-up

Journal of Perinatology

Volumn 23, Issue 4, 2003, Pages 300-303

  Clark, Reese H ^a   Huckaby, Jeryl L ^b   Kueser, Thomas J ^c   Walker, Marshall W ^d   Southgate, W Michael ^e   Perez, Jose A ^f   Roy, Beverly J ^g   Keszler, Martin ^h   Butler, J ⁱ   Wellendorf, K ⁱ   Auten, K ⁱ   Hall, D ⁱ   Ramthun, E ⁱ   Huckaby, J ⁱ   Jain, L ⁱ   Roy, B ⁱ   Seabrook, I ⁱ   Keszler, M ⁱ   Angelus, P ⁱ   Kueser, T ⁱ   Brucoli, L ⁱ   Marsh, D ⁱ   O'Dell, A ⁱ   McGettigan, M ⁱ   Uinn, B ⁱ   Matranga, G ⁱ   Napolitano, A ⁱ   Williams, R ⁱ   Odom, M ⁱ   Perez, J ⁱ   Ramos, J ⁱ   Rathi, M ⁱ   Shukla, A ⁱ   Gardner, T ⁱ   Southgate, M ⁱ   Purohit, D ⁱ   Ballard, S ⁱ   Nussbaum, M ⁱ   Stevens, D ⁱ   Klinghagen, R ⁱ   Walker, W ⁱ   Jenkinson, V ⁱ   Walsh, W ⁱ   Steele, S ⁱ   Canter, B ⁱ   Yoder, B ⁱ   Woodcox, S ⁱ   more..

^a Pediatrics Medical Group Inc   (United States)

^b Children's Healthcare of Atlanta at Egleston   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

^d GREENVILLE HOSPITAL SYSTEM   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f ARNOLD PALMER HOSPITAL FOR CHILDREN   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h GEORGETOWN UNIVERSITY HOSPITAL   (United States)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; OXYGEN; PLACEBO;

ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EXTRACORPOREAL OXYGENATION; FOLLOW UP; GESTATIONAL AGE; HOSPITAL PATIENT; HUMAN; INFANT; INFANT MORTALITY; LOW DRUG DOSE; LUNG DISEASE; MAJOR CLINICAL STUDY; NEUROLOGIC EXAMINATION; NEWBORN; PULMONARY HYPERTENSION; RANDOMIZATION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; BIRTH WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; MALE; NITRIC OXIDE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0038480654     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210908     Document Type: Article

References (12)

1. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Research Group. N Engl J Med 2000;342:469-74.
2. Kinsella JP, Abman SH. Recent developments in inhaled nitric oxide therapy of the newborn. Curr Opin Pediatr 1999;11:121-5.
3. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 2000;136:611-7.
4. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NI/PPHN Study Group. Pediatrics 1995;101:325-34.
5. Kinsella JP, Truog WE, Walsh WF, et al. Randomized multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn. J Pediatr 1997;131:55-62.
6. Roberts Jr. JD, Fineman JR, Morin FC III, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn The Inhaled Nitric Oxide Study Group. N Engl J Med 1997;336:605-10
7. Lipkin PH, Davidson D, Spivak L, Straube R, Rhines J, Chang CT. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 2000;140:306-10.
8. Rosenberg AA. Outcome in term infants treated with inhaled nitric oxide. J Pediatr 2002;140:284-7.
9. Vaucher YE, Dudell GG, Bejar R, Gist K. Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation. J Pediatr 1996;128:109-17.
10. Walsh-Sukys MC, Bauer RE, Cornell DJ, Friedman HG, Stork EK, Hack M. Severe respiratory failure in neonates: mortality and morbidity rates and neurodevelopmental outcomes. J Pediatr 1994;125:104-10.
11. Schwendeman CA, Clark RH, Yoder BA, Null Jr, DM, Gerstmann DR, deLemos RA. Freuency of chronic lung disease in infants with severe respiratory failure treated with high-freuency ventilation and/or extracorporeal membrane oxygenation. Crit Care Med 1992;20:372-7.
12. Bennett CC, Johnson A, Field DJ, Elbourne D. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet 2001;357:1094-6.